BIRC5 and non-small cell lung carcinoma: These effects were well correlated with the CuB-mediated inhibition of angiogenesis mediators MMP-2, Survivin and VEGF in NSCLC cells as well as MMP-2 and VEGF in the NNK-induced lung tumors.